87 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Friedenthal Financial

Friedenthal Financial purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 87 shares of the healthcare conglomerate’s stock, valued at approximately $51,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Swedbank AB bought a new position in UnitedHealth Group during the 1st quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP grew its holdings in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its position in UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after acquiring an additional 821,050 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Barclays lifted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Wells Fargo & Company raised their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

Get Our Latest Research Report on UNH

UnitedHealth Group Stock Up 0.6 %

UnitedHealth Group stock opened at $569.61 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm’s fifty day simple moving average is $584.42 and its 200-day simple moving average is $533.63. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $525.99 billion, a P/E ratio of 37.77, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the previous year, the company earned $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 55.70%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.